The Kaiser group develops and uses chemical biology approaches to investigate diverse aspects of regulated proteolysis and to study the molecular mechanisms behind bioactive small molecule action. Our interests are however not limited to basic research; rather, we aim to capitalize on our scientific findings for drug discovery or other medicinal applications.

Research Projects

European Regional Development Fund
(Europäischer Fonds für regionale Entwicklung)
EFRE Project

Inhibitors of the serin protease HTRA1 for the treatment of age-related blindness (2018-2022)

Participating Institutions
Lead Discovery Center GmbH Dortmund
University of Duisburg-Essen

Efre logo
nrw logo

Press release